Immune Tolerance Induction in Haemophilia A Patients Using Wilate - A Canadian Study
Phase of Trial: Phase IV
Latest Information Update: 31 Jul 2018
At a glance
- Drugs Factor VIII/von Willebrand factor (Primary)
- Indications Haemophilia A
- Focus Therapeutic Use
- Acronyms PREVAIL
- Sponsors Octapharma
- 19 Jul 2018 Status changed from not yet recruiting to recruiting.
- 05 Jun 2018 Planned End Date changed from 1 Dec 2026 to 1 Dec 2027.
- 05 Jun 2018 Planned primary completion date changed from 1 Dec 2026 to 1 Dec 2027.